Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Treatment Pattern, Clinical Outcome and Healthcare Resource Utilization Associated With Chinese Newly Diagnosed Patients With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP): A Retrospective Observational Study

Observational medical record review of newly diagnosed CML-CP participants in China

Inclusion Criteria:

• Ph+ CML-CP patients who were diagnosed between August 1, 2014 to August 1, 2016
• 18 years or older at time of diagnosis

Exclusion Criteria:

• Participants once enrolled in any interventional clinical trial for CML
• Participants whose records are not available

Other protocol defined inclusion/exclusion criteria could apply